The E3 ubiquitin ligase itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner

Cell Death and Disease

Volumn 4, Issue 3, 2013, Pages

  Suryaraja, R ^a   Anitha, M ^a   Anbarasu, K ^a   Kumari, G ^a   Mahalingam, S ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Acetylation; Cell Cycle; Itch; RASSF5; Ubiquitination

Indexed keywords

PROTEASOME; PROTEIN; RASSF5 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ITCH PROTEIN, HUMAN; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN BINDING; RASSF5 PROTEIN, HUMAN; REPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE; BINDING SITE; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN DOMAIN; TUMOR CELL LINE;

ACETYLATION; APOPTOSIS; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MONOMERIC GTP-BINDING PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; PROTEOLYSIS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84875878283     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.91     Document Type: Article

References (38)

1. Bee C, Moshnikova A, Mellor CD, Molloy JE, Koryakina Y, Stieglitz B et al. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation. J Biol Chem 2010; 285: 16258-16266.
2. Calvisi DF, Donninger H, Vos MD, Birrer MJ, Gordon L, Leaner V et al. NORE1A tumor suppressor candidate modulates p21CIP1 via p53. Cancer Res 2009; 69: 4629-4637.
3. Kumari G, Singhal PK, Suryaraja R, Mahalingam S. Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation. J Mol Biol 2010; 397: 89-109.
4. Park J, Kang SI, Lee SY, Zhang XF, Kim MS, Beers LF et al. Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis. J Biol Chem 2010; 285: 35029-35038.
5. Vavvas D, Li X, Avruch J, Zhang XF. Identification of Nore1 as a potential Ras effector. J Biol Chem 1998; 273: 5439-5442.
6. Harvey K, Tapon N. The Salvador-Warts-hippo pathway - An emerging tumour-suppressor network. Nat Rev Cancer 2007; 7: 182-191.
7. Hwang E, Ryu KS, Paakkonen K, Guntert P, Cheong HK, Lim DS et al. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA 2007; 104: 9236-9241.
8. Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008; 13: 188-192.
9. Djos A, Martinsson T, Kogner P, Caren H. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Mol Cancer 2012; 11: 40.
10. Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. Int J Cancer 2008; 123: 389-394.
11. Kumari G, Singhal PK, Rao MR, Mahalingam S. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. J Mol Biol 2007; 367: 294-1311.
12. Bedford MT, Chan DC, Leder P. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J 1997; 16: 2376-2383.
13. Ilsley JL, Sudol M, Winder SJ. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal 2002; 14: 183-189.
14. Macias MJ, Wiesner S, Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett 2002; 513: 30-37.
15. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 2008; 283: 5496-5509.
16. Ho KC, Zhou Z, She YM, Chun A, Cyr TD, Yang X. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability. Proc Natl Acad Sci USA 2011; 108: 4870-4875.
17. Salah Z, Melino G, Aqeilan RI. Negative regulation of the hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res 2011; 71: 2010-2020.
18. Sudol M. Newcomers to the WW domain-mediated network of the hippo tumor suppressor pathway. Genes Cancer 2011; 1: 1115-1118.
19. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al. Inactivation of YAP oncoprotein by the hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21: 2747-2761.
20. Levy D, Reuven N, Shaul Y. A regulatory circuit controlling Itch-mediated p73 degradation by Runx. J Biol Chem 2008; 283: 27462-27468.
21. Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO 2005; 24: 836-848.
22. Aoyama Y, Avruch J, Zhang XF. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene 2004; 23: 3426-3433.
23. Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004; 306: 271-275.
24. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci USA 2005; 102: 11278-11283.
25. Oka T, Mazack V, Sudol M. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 2008; 283: 27534-27546.
26. Spangea S, Wagner T, Heinzel T, Kramer OH. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 2009; 41: 185-198.
27. Wang F, Chan CH, Chen K, Guan X, Lin HK, Tong Q. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 2012; 31: 1546-1557.
28. Yang C, Zhou W, Jeon MS, Demydenko D, Harada Y, Zhou H et al. Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Mol Cell 2006; 21: 135-141.
29. Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007; 5: 981-989.
30. Liu X,Wang L, Zhao K, Thompson PR, Hwang Y, Marmorstein R et al. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 2008; 451: 846-850.
31. Visser S, Yang X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 2010; 9: 3892-3903.
32. Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 1995; 121: 1053-1063.
33. Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008; 14: 10-21.
34. Salah Z, Aqeilan RI. WW domain interactions regulate the hippo tumor suppressor pathway. Cell Death Dis 2011; 2: e172.
35. Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ et al. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Eur J Surg Oncol 2012; 38: 523-530.
36. Liao ZW, Zhou TC, Tan XJ, Song XL, Liu Y, Shi XY et al. High expression of p300 is linked to aggressive features and poor prognosis of nasopharyngeal carcinoma. J Transl Med 2012; 10: 110.
37. Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G et al. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol Cell Biol 2000; 20: 8526-8535.
38. Giri H, Muthuramu I, Dhar M, Rathnakumar K, Ram U, Dixit M. Protein tyrosine phosphatase SHP2 mediates chronic insulin-induced endothelial inflammation. Arterioscler Thromb Vasc Biol 2012; 32: 1943-1950.